The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2023
Filed:
Oct. 09, 2020
Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage forms
Applicant:
Chemapotheca, Llc, Delmar, NY (US);
Inventors:
Karl Popp, Schodack Landing, NY (US);
Harold Meckler, Delmar, NY (US);
Assignees:
Pharmapotheca A, Inc., Delmar, NY (US);
Chemapotheca, LLC, Delmar, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61K 47/64 (2017.01); A61K 9/50 (2006.01); A61K 47/54 (2017.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 9/2031 (2013.01); A61K 9/2866 (2013.01); A61K 9/5026 (2013.01); A61K 9/5047 (2013.01); A61K 47/542 (2017.08); A61K 47/64 (2017.08);
Abstract
The invention also relates to pharmaceutical compositions comprising highly pure amphetamine and amphetamine-class compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds, and to methods of manufacturing, delivering, and using the amphetamine compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds.